Ascletis Begins Dosing in U.S. Phase IIa Trial of...
Category : Clinical Trial Update 4 July 2025Overview Ascletis Pharma Inc. (HKEX: 1672, ""Ascletis"") announces today that...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Everest Reports Positive Early Data for EVER001 in...
Category : Clinical Trial Update 4 July 2025Overview Everest Medicines a biopharmaceutical company focused on the discovery, clinical develop...
Gain Therapeutics completes enrollment in phase 1b...
Category : Clinical Trial Update 3 July 2025Overview Gain Therapeutics, Inc, a clinical-stage biotechnology company leading the discovery and...
Novartis provides update on Phase III GCAptAIN stu...
Category : Clinical Trial Update 3 July 2025Novartis today announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx®...
Moderna reports positive results from phase 3 effi...
Category : Clinical Trial Update 3 July 2025Overview Moderna, Inc, a leader in the creation of the field of mRNA medicine, announced positive...
Latest Newsletter Post
-
Everest Reports Positive Early Data..
4 July 2025
-
Ascletis Begins Dosing in U.S. Phas..
4 July 2025
-
Repronovo announces enrollment in U..
3 July 2025
-
Moderna reports positive results fr..
3 July 2025
-
Gain Therapeutics completes enrollm..
3 July 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com